Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
Published on: August 4, 2023
TULA-2 Deficiency Enhances Platelet Functional Responses to CLEC-2 Agonists
John C Kostyak1, Benjamin R Mauri1, Carol Dangelmaier1
1Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States.
T-cell ubiquitin ligand-2 (TULA-2) negatively regulates C-type lectin-like receptor 2 (CLEC-2) signaling in platelets. Its absence enhances platelet aggregation and secretion by boosting spleen tyrosine kinase (Syk) phosphorylation.
Area of Science:
- Hematology
- Immunology
- Cell Signaling
Background:
- Platelet activation is crucial for hemostasis, involving surface receptors like CLEC-2.
- CLEC-2 signals through spleen tyrosine kinase (Syk), a key mediator of platelet responses.
- T-cell ubiquitin ligand-2 (TULA-2) is a phosphatase highly expressed in platelets, known to interact with Syk.
Purpose of the Study:
- To investigate the role of TULA-2 in regulating CLEC-2-mediated platelet signaling.
- To determine if TULA-2 affects Syk phosphorylation and activity downstream of CLEC-2.
Main Methods:
- Utilized TULA-2 knockout mice and wild-type littermate controls.
- Stimulated platelets with CLEC-2 antibodies and rhodocytin.
- Assessed platelet aggregation, secretion, Syk phosphorylation (Y346), and downstream signaling molecules (PLCγ2, SLP-76).
Main Results:
- TULA-2 deficiency significantly enhanced platelet aggregation and secretion upon CLEC-2 stimulation.
- Syk phosphorylation at Y346 and downstream signaling molecule PLCγ2 phosphorylation were increased in TULA-2 knockout platelets.
- Enhanced kinetics and amount of thromboxane production were observed in TULA-2 deficient platelets.
Conclusions:
- TULA-2 acts as a negative regulator of CLEC-2 signaling in platelets.
- TULA-2 dephosphorylates Syk at Y346, thereby restraining Syk-mediated downstream signaling.
- These findings elucidate a novel regulatory mechanism in platelet activation pathways.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
2° Amines to N-Nitrosamines: Reaction with NaNO2
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
SN2 Reaction: Kinetics
In a chemical reaction, a relationship exists between the concentration of reactants and the rate at which the reaction proceeds. The study to measure this relationship is known as the kinetics of a chemical reaction. Kinetic studies are used to deduce the rate law of a chemical reaction, which provides information about the species involved during the transition state of the rate-determining step. Thus, kinetic studies help to derive the mechanism of a...
SN2 Reaction: Mechanism
The presence of the more electronegative halogen in the substrate creates a polarized carbon-halide bond. The halide pulls the electron cloud generating an electrophilic center at the carbon atom. Thus, the carbon atom carries a partial positive charge while the halide has a...

